It has also been reported that IL-10 is an anti-inflammatory cytokine that prevents angiogenesis by downregulating VEGF expression [77], so that its levels are lower in patients affected by proliferative DR than control subjects [78] and that the presence of high levels of IL-10 reduce the risk of DR in patients with DM [79,80]. Here, IL10 is linked to diabetes mellitus.